Aggregate revenue of biopharma divestiture candidates by therapy area 2017
This statistic depicts the total aggregate revenues of divestiture candidates among top biopharmaceutical companies as of 2017, by therapeutic area. In oncology, aggregate revenues from divestiture candidates were about 18.5 billion U.S. dollars.